Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 1 alpha 1 pseudogene 3 (CSNK1A1P3) is a genomic sequence classified as a pseudogene related to the protein-coding gene casein kinase 1 alpha 1 (CSNK1A1). Pseudogenes are generally non-functional remnants of genes, often arising from gene duplication or retrotransposition events. Unlike functional genes, CSNK1A1P3 does not code for a protein product and does not serve as an enzyme, receptor, or other type of molecular target relevant for drug development. While a few pseudogenes and their RNA products have been shown to regulate gene expression or participate in cellular processes as long non-coding RNAs, no specific functional, biomarker, or therapeutic relevance has been reported for CSNK1A1P3[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase 1 alpha 1 pseudogene 3 (CSNK1A1P3).